GrotheyA., Van CutsemE., SobreroA.Regorafenib monotherapy for previously treat-ed metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, pla-cebo-controlled, phase 3 trial.Lancet.2013; 381(9863): 303–312.
2.
MayerR.J., Van CutsemE., FalconeA.Randomized trial of TAS-102 for refractory metastatic colorectal cancer.N Engl J Med.2015; 372(20): 1909–1919.
3.
CremoliniC., PietrantonioF.How the lab is changing our view of colorectal cancer.Tumori.2016; 102(6): 541–547.
4.
PietrantonioF., MiceliR., RimassaL.Estimating 12-weeks death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram.Ann Oncol. Epub2016 Nov 17.
